Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Henry

Showing results (161-170 of 278) with videos related to

Pageof 28
Sort By:
Alimentary Pharmacology & Therapeutics|May 2, 2024
Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real-world U.S. patients, 2003-2021Sally Tran, Biyao Zou, KeeSeok Lee, et al.
Clinical and Molecular Hepatology|September 19, 2022
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approachMichael H Le, Yee Hui Yeo, Biyao Zou, et al.
JAMA Network Open|February 2, 2022
County-Level Variation in Cirrhosis-Related Mortality in the US, 1999-2019Audrey Y Ha, Michael H Le, Linda Henry, et al.
Plos One|May 1, 2018
Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysisHaesuk Park, Donghak Jeong, Pauline Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 14, 2024
Food Swamps and Food Deserts Impact on Metabolic Dysfunction-Associated Steatotic Liver Disease Mortality in US CountiesAnnette Paik, Linda Henry, Leyla de Avila, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2009
The use of spirometry testing prior to cardiac surgery may impact the Society of Thoracic Surgeons risk prediction score: a prospective study in a cohort of patients at high risk for chronic lung diseaseNiv Ad, Linda Henry, Linda Halpin, et al.
American Journal of Preventive Medicine|July 2, 2021
Cascade of Hepatitis C Virus Care Among Patients With Substance Use DisordersXinyi Jiang, Robert L Parker, Scott Martin Vouri, et al.
JAMA Network Open|December 8, 2022
Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United StatesVy H Nguyen, Leslie Kam, Yee Hui Yeo, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disordersXinyi Jiang, Hyun Jin Song, Wei Wang, et al.
Journal of Hepatology|October 20, 2018
Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatmentFanpu Ji, Yee Hui Yeo, Caini He, et al.
Pageof 28

Showing results (161-170 of 278) with videos related to

Sort By:
Pageof 28
Alimentary Pharmacology & Therapeutics|May 2, 2024
Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real-world U.S. patients, 2003-2021Sally Tran, Biyao Zou, KeeSeok Lee, et al.
Clinical and Molecular Hepatology|September 19, 2022
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approachMichael H Le, Yee Hui Yeo, Biyao Zou, et al.
JAMA Network Open|February 2, 2022
County-Level Variation in Cirrhosis-Related Mortality in the US, 1999-2019Audrey Y Ha, Michael H Le, Linda Henry, et al.
Plos One|May 1, 2018
Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysisHaesuk Park, Donghak Jeong, Pauline Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 14, 2024
Food Swamps and Food Deserts Impact on Metabolic Dysfunction-Associated Steatotic Liver Disease Mortality in US CountiesAnnette Paik, Linda Henry, Leyla de Avila, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2009
The use of spirometry testing prior to cardiac surgery may impact the Society of Thoracic Surgeons risk prediction score: a prospective study in a cohort of patients at high risk for chronic lung diseaseNiv Ad, Linda Henry, Linda Halpin, et al.
American Journal of Preventive Medicine|July 2, 2021
Cascade of Hepatitis C Virus Care Among Patients With Substance Use DisordersXinyi Jiang, Robert L Parker, Scott Martin Vouri, et al.
JAMA Network Open|December 8, 2022
Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United StatesVy H Nguyen, Leslie Kam, Yee Hui Yeo, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disordersXinyi Jiang, Hyun Jin Song, Wei Wang, et al.
Journal of Hepatology|October 20, 2018
Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatmentFanpu Ji, Yee Hui Yeo, Caini He, et al.
Pageof 28